1. Home
  2. IMMP vs NODK Comparison

IMMP vs NODK Comparison

Compare IMMP & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • NODK
  • Stock Information
  • Founded
  • IMMP 1987
  • NODK 1946
  • Country
  • IMMP Australia
  • NODK United States
  • Employees
  • IMMP N/A
  • NODK N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • NODK Property-Casualty Insurers
  • Sector
  • IMMP Health Care
  • NODK Finance
  • Exchange
  • IMMP Nasdaq
  • NODK Nasdaq
  • Market Cap
  • IMMP 251.8M
  • NODK 261.8M
  • IPO Year
  • IMMP N/A
  • NODK 2017
  • Fundamental
  • Price
  • IMMP $1.57
  • NODK $12.92
  • Analyst Decision
  • IMMP Buy
  • NODK
  • Analyst Count
  • IMMP 1
  • NODK 0
  • Target Price
  • IMMP $7.00
  • NODK N/A
  • AVG Volume (30 Days)
  • IMMP 111.5K
  • NODK 16.3K
  • Earning Date
  • IMMP 02-27-2025
  • NODK 08-07-2025
  • Dividend Yield
  • IMMP N/A
  • NODK N/A
  • EPS Growth
  • IMMP N/A
  • NODK N/A
  • EPS
  • IMMP N/A
  • NODK N/A
  • Revenue
  • IMMP $3,019,249.00
  • NODK $322,139,000.00
  • Revenue This Year
  • IMMP $50.37
  • NODK N/A
  • Revenue Next Year
  • IMMP N/A
  • NODK N/A
  • P/E Ratio
  • IMMP N/A
  • NODK $44.10
  • Revenue Growth
  • IMMP 24.11
  • NODK 3.15
  • 52 Week Low
  • IMMP $1.32
  • NODK $12.01
  • 52 Week High
  • IMMP $2.80
  • NODK $17.24
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 36.75
  • NODK 53.26
  • Support Level
  • IMMP $1.51
  • NODK $12.35
  • Resistance Level
  • IMMP $1.63
  • NODK $13.33
  • Average True Range (ATR)
  • IMMP 0.07
  • NODK 0.48
  • MACD
  • IMMP -0.03
  • NODK 0.02
  • Stochastic Oscillator
  • IMMP 14.34
  • NODK 67.20

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.

Share on Social Networks: